Extending Time to Reperfusion with Mild Therapeutic Hypothermia: A New Paradigm for Providing Primary Percutaneous Coronary Intervention to Remote ST Segment Elevation Myocardial Infarction Patients.


Journal

Therapeutic hypothermia and temperature management
ISSN: 2153-7933
Titre abrégé: Ther Hypothermia Temp Manag
Pays: United States
ID NLM: 101543518

Informations de publication

Date de publication:
Mar 2021
Historique:
pubmed: 11 3 2020
medline: 29 10 2021
entrez: 11 3 2020
Statut: ppublish

Résumé

Primary percutaneous coronary intervention (PPCI) is the preferred treatment for acute ST segment elevation myocardial infarction (STEMI). The goal is reperfusion within 90 minutes of first medical contact (FMC) or 120 minutes if transfer is needed. Otherwise, fibrinolytic therapy is recommended. Mild therapeutic hypothermia (MTH) (≤35°C) before coronary reperfusion decreases myocardial infarct size. If applied before reperfusion, hypothermia could potentially lengthen the FMC-reperfusion time without increasing infarct size. Thirty-six swine had their mid left anterior descending coronary artery acutely occluded. All animals had an initial 30 minutes of occlusion to simulate typical delay before seeking medical attention. Eighteen animals were studied under normothermic conditions with reperfusion after an additional 40 minutes (the porcine equivalent of a 120-minute clinical FMC to reperfusion time) and 18 were treated with hypothermia but not reperfused until another 80 minutes (clinical equivalent of 240 minutes). Primary outcome was myocardial infarct size (infarct/area at risk [AAR]) at 24 hours. The two groups differed in systemic temperature at the time of reperfusion (39.1°C ± 1.0°C vs. 35.5°C ± 0.7°C;

Identifiants

pubmed: 32155385
doi: 10.1089/ther.2019.0039
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

45-52

Auteurs

Madhan Shanmugasundaram (M)

Department of Cardiology, Sarver Heart Center, University of Arizona, Tucson, Arizona, USA.

Huu Tam Truong (HT)

Department of Cardiology, Loma Linda University, Loma Linda, California, USA.

Ahmed Harhash (A)

Department of Cardiology, Sarver Heart Center, University of Arizona, Tucson, Arizona, USA.

David Ho (D)

Department of Cardiology, Sarver Heart Center, University of Arizona, Tucson, Arizona, USA.

Arielle Tran (A)

Department of Cardiology, Sarver Heart Center, University of Arizona, Tucson, Arizona, USA.

Nicole Smith (N)

Department of Cardiology, Sarver Heart Center, University of Arizona, Tucson, Arizona, USA.

Brian Ciurlino (B)

Department of Cardiology, Sarver Heart Center, University of Arizona, Tucson, Arizona, USA.

Marko Noc (M)

Department of Cardiology, University Medical Center, Ljubljana, Slovenia.

Paul Hsu (P)

Department of Biostatistics and Epidemiology, University of Arizona, Tucson, Arizona, USA.

Karl B Kern (KB)

Department of Cardiology, Sarver Heart Center, University of Arizona, Tucson, Arizona, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH